Drug Eluting Stents Market
According to Intent Market Research, the Drug Eluting Stents Market is expected to grow from USD 7.4 billion in 2023 at a CAGR of 8.0% to touch USD 12.7 billion by 2030. The Drug Eluting Stents Market is dominated by key players such as Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cook Medical, Cardinal Health, Inc., Biosensors International Group, Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Sahajanand Medical Technologies Pvt. Ltd., Meril Life Sciences Pvt. Ltd., Translumina Therapeutics LLP.